[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Mann Eye Institute\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":61},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,38],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100614576","iop-reduction-in-pigmentary-glaucoma-using-dslt-100614576",false,"NCT07281391","IOP Reduction in Pigmentary Glaucoma Using DSLT","Direct Selective Laser Trabeculoplasty Providing Effective Intraocular Pressure Reduction in Pigmentary Glaucoma Patients","Inclusion Criteria:\n\n* Adult patients with pigmentary dispersion syndrome with elevated IOP or mild to moderate (based on AAO Preferred Practice Program criteria) pigmentary glaucoma with glaucomatous optic neuropathy and corresponding visual field\u002FRNFL loss.\n* Treatment naive, or washed out IOP ranging from ≥18-34 mmHg\n* Central corneal thickness (CCT) 480-600 µm\n* Able to complete medication washout and follow-up\n\nExclusion Criteria:\n\n* Prior incisional glaucoma surgery or glaucoma-related procedures in the study eye\n* Prior laser trabeculoplasty \\\u003C3 years\n* Prior intraocular surgery and refractive surgery, except for cataract surgery unless greater than 2 years\n* Patients anticipating cataract surgery within the follow-up period\n* History of ocular inflammation and infection\n* All other secondary glaucoma including exfoliative\n* Patients unable to have DSLT treatment","ALL",{"count":18,"type":19},45,"ESTIMATED","OBSERVATIONAL","This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.",[23,24],"Pigmentary Dispersion Syndrome","Pigmentary Dispersion Glaucoma","RECRUITING","2026-04-08",{"date":28,"type":29},"2026-04-09","ACTUAL",{"date":31,"type":29},"2026-03-19",{"date":33,"type":19},"2027-04-01",{"name":35,"class":36},"Mann Eye Institute","OTHER",1,{"id":39,"slug":40,"hasResults":11,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":16,"minAge":45,"maxAge":46,"enrollmentInfo":47,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":49,"conditions":50,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":37},"100599465","patient-reported-outcomes-with-wavelight-plus-lasik-100599465","NCT07084844","Patient Reported Outcomes With WaveLight Plus LASIK","Patient Reported Outcomes and Satisfaction With Wavelight Plus LASIK","Inclusion Criteria:\n\n* Between the ages of 18 and 39\n* Meet the standard care requirements for LASIK\n* Spherical equivalent (SE) more than -1.00D and up to -9.00 diopters\n* Myopia ≤ -8.00 sphere (in minus cylinder format) and up to -3.00D astigmatism\n* SE difference between the manifest refraction and the Sightmap measured SE being less than 0.75D\n* Minimum residual stromal bed thickness of 250 µm\n* If currently wearing contact lenses:\n\n  * Soft CTL wearers discontinue for minimum 3 days\n  * RGP CTL wearers discontinue for 1 month per decade of wear\n* Stable refraction (2 consecutive manifest refractions within 0.25 SE)\n* Stable K readings (2 consecutive K readings in 2 consecutive visits)\n* Willing and able to complete all post-operative visits\n* Pre-surgery BCDVA of 20\u002F20 (0.00 logMAR) or better in each eye.Mesopic pupil size ≥ 4.5mm\n\nExclusion Criteria:\n\n* Subjects with any prior ocular surgery\n* Subjects with topographic evidence of keratoconus, or ectasia\n* Subjects with autoimmune diseases\n* Subjects who are pregnant or nursing\n* Systemic disease likely to affect wound healing, such as diabetes and severe atopy\n* Any ocular disease (including un-controlled dry eye) which in the investigator's opinion would affect the outcome of refractive surgery","18 Years","39 Years",{"count":48,"type":19},52,"This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and the Quality-of-Life Impact of Refractive Correction (QIRC) Questionnaire.",[51,52],"Myopia","Astigmatism","2025-09-08",{"date":55,"type":29},"2025-09-15",{"date":57,"type":29},"2025-09-05",{"date":59,"type":19},"2026-09-01",{"name":35,"class":36},""]